Concepedia

Author

Marisa Montes

Hospital Universitario La PazORCID

Also Known As

Ana Carrero, Antoni Noguera-Julian Ignacio Bernardino, Antoni Noguera-Julián, E. Rodríguez, Elena Bermúdez, F J Zamora, Ignacio Bernardino, J J González-García, J R Arribas, J. J. Jusdado

207

Publications

3.4K

Citations

32

H-Index

49

Concepts

All Affiliations

Hospital Universitario La PazHospital General Universitario Gregorio MarañónHospital Universitario Ramón y CajalHospital Clínico San CarlosBiogipuzkoa Health Research Institute
MM

About

Marisa Montes is an author at Hospital Universitario La Paz specializing in medicine, hiv, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

688

2

Epidemiology

5

5

199

3

Health Sciences

2

2

44

4

Public Health

2

2

109

5

Blood Transplantation

1

1

17

Marisa Montes

×

50

Publications

2.4K

Citations

26

H-Index

YearCitations

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Paul E. Sax, Anton Pozniak, Marisa Montes,

The Lancet

2017

385

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

Deanna Kerrigan, Andrea Mantsios, Miguel Górgolas,

PLoS ONE

2018

163

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Juan Berenguer, Elisa Boucourt Rodríguez, Pilar Miralles,

Clinical Infectious Diseases

2012

159

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression

José Ramón Arribas, Federico Pulido, Rafaël Delgado,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2005

149

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

José Ramón Arribas, Rafaël Delgado, Alberto Arranz,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2009

108

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, María Dolores del Toro, Alberto M. Borobia,

The Lancet Infectious Diseases

2021

98

Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy

Juan Berenguer, Pilar Miralles, Josep‐María Ribera,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2008

84

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors

Marisa Montes, Federico Pulido, Carlos Barrós,

Journal of Antimicrobial Chemotherapy

2005

81

The natural history of liver cirrhosis in HIV–hepatitis C virus-coinfected patients

María López-Diéguez, Marisa Montes, José Francisco Pascual Pareja,

AIDS

2011

73

All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice

Juan Berenguer, Ángela Gil‐Martin, Inmaculada Jarrín,

Hepatology

2018

72

Page 1